论文部分内容阅读
目的观察慢性支气管炎患者采用特布他林联合布地奈德雾化吸入治疗的临床效果。方法资料选取2012年6月~2014年1月本院诊治的慢性支气管炎患者108例,按照完全抽样法1:1分成两组,每组各54例;对照组予常规治疗,观察组予对照组基础上采取特布他林联合布地奈德雾化吸入治疗,分析两组患者临床治疗效果和不良反应发生率情况。结果治疗后观察组临床治疗效果优于对照组(P<0.05);两组患者均未发生严重不良反应,且不良反应发生率无明显差异(P>0.05)。结论慢性支气管炎患者予特布他林联合布地奈德雾化吸入治疗,具有高效性和安全性的特点。
Objective To observe the clinical effects of inhalation of terbutaline combined with budesonide inhalation in patients with chronic bronchitis. METHODS: A total of 108 patients with chronic bronchitis who were diagnosed and treated in our hospital from June 2012 to January 2014 were divided into two groups according to the sampling method of 1: 1, 54 cases in each group. The control group was given routine treatment and the observation group was given the control Group based on the combination of terbutaline and budesonide inhalation therapy, analysis of two groups of patients with clinical treatment and adverse reaction rates. Results After treatment, the clinical efficacy of the observation group was better than that of the control group (P <0.05). No serious adverse reactions occurred in both groups, and the incidence of adverse reactions showed no significant difference (P> 0.05). Conclusion In patients with chronic bronchitis, terbutaline combined with budesonide inhalation therapy has the characteristics of high efficiency and safety.